Login
$HIND
$1.53 -$0.05 (3.16%) Close

$HIND SEC Filings

Filed On Filing
12 Nov 2026 QUARTERLY REPORT
03 Sep 2026 Form 4: Jolly Mohanjit, Director

Granted 120,000 Stock Option (right to buy)

01 Sep 2026 Form 3: Leonard Jerry, Chief Financial Officer

No securities owned

28 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation

This Consulting Agreement (the “Agreement”) is made effective as of September 1, 2026 (the “Effective Date”), by and between Vyome Holdings, Inc., a Delaware corporation, with its principal place of business at Harvard Square, One Miffli...

25 Aug 2026 8-K: Results of Operations and Financial Condition

Vyome Holdings Reports Second Quarter 2026 Results Highlighted By Advancement Of Lead VT-1953 Program, Pipeline Expansion And Strong Balance Sheet

12 Aug 2026 QUARTERLY REPORT
29 May 2026 8-K: Results of Operations and Financial Condition

Vyome has signed an agreement with Impetis Biosciences Limited, a TATA Enterprise, to in-license two selective JAK inhibitor assets, opening access to a large and growing ~$57B global market1

12 May 2026 QUARTERLY REPORT
29 Apr 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders

I, CHARUNI PATIBANDA-SANCHEZ, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE RESTATED CERTIFICATE OF “VYOME HOLDINGS, INC.”, FILED IN THIS OFFICE ON THE TWENTY-FOURTH DAY OF ...

31 Mar 2026 Proxy statement: annual meeting on April 24, 2026

say-on-pay vote

20 Mar 2026 PRELIMINARY PROXY STATEMENT
18 Mar 2026 ANNUAL REPORT
25 Feb 2026 8-K: Entry into a Material Definitive Agreement; Other Events

This Notes Purchase and Exchange Agreement (this “Agreement”) is entered into as of February 20, 2026 (the “Effective Date”) by and among (i) LiveChain, Inc., a Nevada corporation (“LICH”); (ii) LICH AI, Inc., a Delaware corporation and ...

13 Feb 2026 8-K: Regulation FD Disclosure

VT - 1953 in Treating Symptoms of Malignant Fungating Wounds (MFW) PHASE 2 IST STUDY RESULTS & NEXT STEPS © Vyome Holdings, Inc. February 2026

28 Jan 2026 8-K: Regulation FD Disclosure; Other Events

1 U.S. Market & Product Assessment and Valuation of VT - 1953 for the Treatment of Symptoms of Malignant Fungating Wounds H1 2026

23 Dec 2025 8-K: Entry into a Material Definitive Agreement

This letter of intent (this “LOI”) outlines the general terms and conditions of a prospective transaction (as further described herein, the “Transaction”) between LiveChain, Inc., a Delaware corporation (“LICH”), Remus Capital Series B I...

26 Nov 2025 PROSPECTUS
19 Nov 2025 8-K: Results of Operations and Financial Condition

Completed a streamlined Nasdaq listing, with a 100% common stock capital structure

19 Nov 2025 Form 4: Pomichter Stanley D Iii, Director

Granted 17,833 Stock Option (right to buy)

19 Nov 2025 Form 3: Pomichter Stanley D Iii, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support